Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Share Facebook Twitter LinkedIn Pinterest Email Full highlights from Sunday’s NASCAR Cup Series All-Star Open at North Wilkesboro Speedway.
